Author name: Lisa Ferguson

Lisa Ferguson is an award-winning writer and editor who is passionate about politics, health, business, and finance. In her free time, Lisa loves to read nonfiction books and watch documentaries about current affairs. Her favorite subjects are health care policy, climate change, and social justice issues like immigration reform.

Avatar of Lisa Ferguson
3005147444aa693aaab7da39826718f8

The first glow-in-the-dark animals may have been ancient corals deep in the ocean

WASHINGTON (AP) — Many animals can glow in the dark. Fireflies famously blink on summer evenings. But most animals that light up are found in the depths of the ocean. In a new study, scientists report that deep-sea corals that lived 540 million years ago may have been the first animals to glow, far earlier […]

The first glow-in-the-dark animals may have been ancient corals deep in the ocean Read More »

4ad73d551544196fc429cef7f7ca03c1

Unprecedented images reveal jaw-dropping features of Jupiter’s ‘tortured moon’

Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. Close flybys of Io, one of Jupiter’s moons and the most volcanically active world in our solar system, have revealed a lava lake and a towering feature called “Steeple Mountain” on the moon’s alien surface. NASA’s

Unprecedented images reveal jaw-dropping features of Jupiter’s ‘tortured moon’ Read More »

im 400296

Regulators probe potential use by big banks of nondisclosure agreements to discourage whistleblowers: report

Some of the largest U.S. banks are being asked by the Commodities Futures Trading Commission to provide details about nondisclosure agreements for employees in an effort to protect potential whistleblowers, according to a report by Bloomberg. Source link

Regulators probe potential use by big banks of nondisclosure agreements to discourage whistleblowers: report Read More »

66268d8c0a3a8.image

Young girl survives cancer thanks to little sister’s lifesaving donation: 'A perfect match'

A young girl in the U.K. is in cancer remission thanks to her sister’s lifesaving bone marrow donation. Ruby Leaning, 10, was diagnosed with acute lymphoblastic leukemia after collapsing on the school playground in Jan. 2020, according to SWNS, the British news service. The rare blood cancer required an urgent bone marrow transplant to keep

Young girl survives cancer thanks to little sister’s lifesaving donation: 'A perfect match' Read More »

ba16a7b6b08ed7305b1399c866a8f3c8

Scientists say USDA is sharing too little data too slowly on H5N1 flu

When the US Department of Agriculture announced late Sunday that it had publicly posted new data from its investigation into a bird flu outbreak in cattle, scientists eagerly searched a well-known platform used globally to share the genetic sequences of viruses. The sequences weren’t there. As of Tuesday morning, they still aren’t. Researchers looking to

Scientists say USDA is sharing too little data too slowly on H5N1 flu Read More »

861eeb03ebb1c62d39e84ab0b33bbd50

Building rockets and looking for life on Venus: Q&A with Rocket Lab's Peter Beck

COLORADO SPRINGS — Extremely busy with an eye on the future. That’s a short and sweet assessment of Rocket Lab’s founder and CEO, Peter Beck. In the pantheon of private space groups, Rocket Lab is a roaring success, and Beck wants to keep it that way. Founded in 2006, Rocket Lab‘s quest to pioneer affordable

Building rockets and looking for life on Venus: Q&A with Rocket Lab's Peter Beck Read More »

im 82281725

‘Extraordinary’ U.S. government debt may mean prolonged bond-market volatility

Roughly $27.5 trillion of debt issued by the U.S. Treasury is in the hands of the public, more than twice as much as 10 years ago and over six times as much as 20 years ago. This fact may be one the biggest reasons why bond-market volatility has picked up, according to strategists and traders.

‘Extraordinary’ U.S. government debt may mean prolonged bond-market volatility Read More »

Alzheimers patient Reuters

Alzheimer's drug embrace slows down as US doctors' reluctance grows

Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer’s, Eisai and Biogen’s Leqembi is facing an unexpected hurdle to widespread use: an entrenched belief among some doctors that treating the memory-robbing disease is futile. Alzheimer’s experts had anticipated bottlenecks due to Leqembi’s requirements, which include additional diagnostic

Alzheimer's drug embrace slows down as US doctors' reluctance grows Read More »

Scroll to Top